A needle-free device that sprays a solution at the skin sounds like a neat answer to the oldest problem in topical skincare: getting an ingredient past the outer layer. Two clinical reports used one such device, called Jet-M, to apply a cocktail that included copper-GHK. The first described a single patient, and the second a small group of people with melasma[1][2].
Both papers are worth reading carefully, because they show how a promising headline can sit on very little evidence.
Key Takeaways
- The cocktail held five ingredients: copper-GHK, oligo-hyaluronic acid, rhodiola extract, tranexamic acid and beta-glucan. The results cannot be credited to GHK-Cu alone[1].
- The first report is a single 59-year-old man treated weekly for 12 weeks. Photographs and skin biopsies showed improvement and more collagen[1].
- The second is a small group with melasma. Its authors say the treatment “may” have depigmenting effects[2].
- Tranexamic acid, an ingredient in the mix, is itself an established melasma treatment, so the pigment result is the hardest one to credit to the copper peptide[3].
What the Device Does
Jet-M is made by an Israeli company, Tav-Tech. The first paper describes it as an instrument for skin resurfacing. When it sprays microdroplets of solution or shoots air at the skin, the superficial layers can be exfoliated and stretched[1]. The authors expected that this would increase the absorption of vitamins and other cosmetic agents through the skin[1].
The second paper describes it the same way, as a device for epidermal peeling that delivers substances by spraying air and microdroplets[2]. The authors call the technique hydroporation. It is a needle-free approach, and the patient in the first report received it without anesthesia and reported no pain[1].
One point to hold on to: the expected increase in absorption is stated as an expectation. Neither abstract reports a measurement of how much of any ingredient got into the skin. The site’s page on microneedling and copper peptide delivery covers a study that did try to measure delivery, which is a very different level of evidence.
The Cocktail
The mixture was a cosmetic preparation of copper-glycyl-L-histidyl-L-lysine, oligo-hyaluronic acid, rhodiola extract, tranexamic acid and beta-glucan, which the authors named the GHR formulation[1]. That puts GHK-Cu in the mix, so the identity question is settled. It also puts four other active ingredients in the same jet.
The abstracts do not give concentrations for any of them. That means even a reader who wanted to compare the dose of copper-GHK with a serum could not do it from these papers. None of the ingredients was tested separately here.
The Single Patient
The first report is a case of one man aged 59. He was treated once a week for 12 weeks with the device and the cocktail[1]. In clinical photographs, the authors say, the wrinkles around the treated eye were greatly decreased[1].
Skin biopsies were taken from treated and untreated areas, which gives the case a built-in comparison. Staining showed more collagen in the upper dermis. Collagen IV was slightly increased, fibrillin-1 and procollagen type 1 were greatly increased, and tropoelastin was also higher[1]. The authors report no adverse effect during or after treatment[1].
A single patient can show that something is feasible and generate a hypothesis. It cannot show that a treatment works in general. One person’s skin can change for many reasons over three months, including season, sun exposure, sleep, other products and the exfoliation caused by the device itself. The abstract does not describe a sham treatment or a device-only comparison.
Note too that the biopsy comparison is treated against untreated skin from the same man. That is a fair internal check, but it does not tell you which part of the treatment caused the difference. The mechanical effect of the jet and each of the five ingredients are all inside that one difference.
The Melasma Group
The next year, a second paper applied the same device and cocktail to melasma, a skin pigmentation condition, in what the authors call a small group of volunteers[2]. The abstract does not state how many people took part, how often they were treated, or for how long.
The team judged results by subjective and objective methods, including a melanin index and an erythema index measured on the skin. Pigmentation and redness were relieved, and both indices fell[2]. Biopsies showed more type IV collagen and procollagen in the upper dermis, and more cells staining for p63 along the basement membrane[2].
The authors read the tissue changes as reconstruction of the extracellular matrix, and they conclude the treatment “may” have depigmenting and redness-reducing effects[2]. The hedge is appropriate. The abstract describes no comparison group, no randomisation and no blinding.
Why the Pigment Result Is the Hardest to Credit to GHK-Cu
One of the five ingredients in the cocktail is tranexamic acid. It is a well-known treatment for melasma in its own right. A 2024 systematic review and meta-analysis of randomized trials pooled 22 studies with 1280 patients and concluded that tranexamic acid, given by mouth, on the skin or by injection, reduced melasma severity scores[3].
The same review notes high variation between studies, particularly for combined treatments, and lists side effects including gastrointestinal discomfort, skin irritation and menstrual irregularities[3].
The reason to mention this is simple. If a melasma group improves after a mixture that contains an ingredient with randomized-trial evidence for melasma, the most economical explanation is that the known ingredient contributed. The paper did not include a cocktail without tranexamic acid, or a tranexamic-acid-only arm, so the pigment change cannot be assigned to the copper peptide.
That is a separate point from the question of whether copper peptides can darken or lighten skin. The site’s page on copper peptides and melanin describes a laboratory study that complicates the lightening idea, and the page on GHK-Cu and hyperpigmentation summarizes the broader evidence.
What Is Missing
The gaps are specific, and they are the questions a reader would want answered.
Delivery. No measurement of copper-GHK in the skin after jet application is reported in either abstract. The claim that the jet increases absorption is a premise, not a result[1][2].
Dose. No ingredient concentrations appear in the abstracts, so the amounts cannot be compared with any other product or study.
Controls. The case has a built-in untreated site and the group study describes none. Neither describes a jet-only or cocktail-without-copper arm[1][2].
Funding and conflicts. The abstracts do not state who paid for the work or whether the authors have ties to the device or the formulation.
Follow-up. We found no other reports combining Jet-M with copper-GHK, so there is no replication to read.
What This Means for a Reader
If you are curious about needle-free delivery, these papers show that a clinic combined a jet device with a cocktail that included a copper peptide and reported tissue changes under the microscope. They do not show that the peptide reached the dermis, and they do not show that it did the work.
If you are looking at a melasma treatment, treat the tranexamic acid as the ingredient with the trial record, and the copper peptide as an unproven passenger. A dermatologist can explain what is established for melasma, including the risks of the treatments that do work. This page cannot diagnose or advise on a pigment problem.
Frequently Asked Questions
Does the Jet-M study show GHK-Cu lightens melasma?
No. The cocktail also contained tranexamic acid, an ingredient with randomized-trial evidence for melasma, plus three other ingredients. The paper did not test the cocktail without tranexamic acid, so the pigment change cannot be assigned to GHK-Cu.
How many people were in the Jet-M studies?
The first was a single 59-year-old man. The second involved what its abstract calls a small group of volunteers with melasma, and the abstract does not give the number.
Did the studies show that the jet pushed GHK-Cu into the skin?
No. The abstracts say the device is expected to increase absorption, but neither reports a measurement of any ingredient in the skin. The tissue changes seen under the microscope do not show which ingredient reached the dermis.
What else was in the cocktail besides copper-GHK?
Oligo-hyaluronic acid, rhodiola extract, tranexamic acid and beta-glucan. The abstracts do not give the concentrations of any of them.
Was there a comparison group?
The single case biopsied both treated and untreated areas of the same man. The melasma abstract describes no comparison group, randomization or blinding.
Is needle-free jet treatment with GHK-Cu proven?
No. The evidence is one case report and one small uncontrolled series, with no replication found. It is a hypothesis-generating report, not proof that the method delivers or works.
References
- Byun SY, et al. Significant improvement in crow’s feet after treatment with Jet-M and a mixed solution of copper-GHK, oligo-hyaluronic acid, rhodiolar extract, tranexamic acid, and β-glucan (GHR formulation). Journal of Cosmetic and Laser Therapy (2016). PMID 27064823
- Chae JB, et al. The effects of hydroporation on melasma with anti-aging cocktail. Journal of Cosmetic Dermatology (2017). PMID 28133891
- Calacattawi R, et al. Tranexamic acid as a therapeutic option for melasma management: meta-analysis and systematic review of randomized controlled trials. The Journal of Dermatological Treatment (2024). PMID 38843906
These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.


